Insulin Modulates Liver Function in a Type i Diabetes Rat Model

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1467-1479

  Nolasco, Eduardo L ^a   Zanoni, Fernando L ^a   Nunes, Fernanda P B ^a   Ferreira, Sabrina S ^a   Freitas, Luiza A ^a   Silva, Mariana C F ^a   Martins, Joilson O ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CLP; Cytokines; Diabetes mellitus; Hepatic; Inflammation; Insulin; Liver; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATININE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOPHANE INSULIN; TUMOR NECROSIS FACTOR ALPHA; UREA; ALLOXAN; ANTIDIABETIC AGENT; CYTOKINE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LIVER DYSFUNCTION; LIVER FUNCTION; LUNG LAVAGE; NONHUMAN; PERITONEUM LAVAGE; PRIORITY JOURNAL; RAT; ANALYSIS; ANIMAL; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; LIVER; MALE; PATHOPHYSIOLOGY; WEIGHT GAIN; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, TYPE 1; HYPOGLYCEMIC AGENTS; INSULIN, ISOPHANE; LIVER; MALE; RATS; RATS, WISTAR; WEIGHT GAIN;

EID: 84936970751     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430311     Document Type: Article

References (30)

1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Crit Care Med 2003;31:1250-1256.
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
3. Moutzouri AG, Athanassiou GA, Dimitropoulou D, Skoutelis AT, Gogos CA: Severe sepsis and diabetes mellitus have additive effects on red blood cell deformability. J Infect 2008;57:147-151.
4. Shah BR, Hux JE: Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003;26:510-513.
5. Geerlings SE, Hoepelman AIM: Immune dysfunction in patients with diabetes mellitus. FEMS Immunol Med Microbiol 1999;26:259-265.
6. Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AL: Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 2000;30:995-1001.
7. De Oliveira Martins J, Meyer-Pflug AR, Alba-Loureiro TC, Melbostad H, Costa Da Cruz JW, Coimbra R, Curi R, Sannomiya P: Modulation of lipopolysaccharide-induced acute lung inflammation: Role of insulin. Shock 2006;25:260-266.
8. Martins JO, Zanoni FL, Martins DO, Coimbra R, Krieger JE, Jancar S, Sannomiya P: Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through Nuclear Factor-B activation in LPS-induced acute lung injury in rats. Shock 2009;31:404-409.
9. Filgueiras LR-Jr, Martins JO, Serezani CH, Capelozzi VL, Montes MBA, Jancar S: Sepsis-induced acute lung injury (ALI) is milder in diabetic rats and correlates with impaired NFB activation. Plos One 2012;7:1-9.
10. Filgueiras LR, Capelozzi VL, Martins JO, Jancar S: Sepsis-induced lung inflammation is modulated by insulin. BMC Pulm Med 2014;14:177.
11. Sunahara KK, Sanomiya P, Martins JO: Briefs on insulin and innate immune response. Cell Physiol Biochem 2012:29:01-08.
12. Angus DC, Abraham E: Intensive insulin therapy in criticall illness-When is the evidence enough? Am J Respir Crit Care Med 2005;172:1358-1359.
13. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckk F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
14. Meyfroidt G, Ingels C, Van Den Berghe G: Glycemic control in the icu. N Engl J Med 2011;364:1280.
15. The Nice-Sugar Study Investigators: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009:360:1283-1297.
16. Van Den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Wijngaerden EV, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical icu. N Engl J Med 2006;354:449-461.
17. Inzucchi SE, Siegel MD: Glucose control in the icu-how tight is too tight? N Engl J Med 2009;360:1346-1349.
18. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW-3rd, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 2009;24Suppl 1:52-7.
19. Keane MP, Strieter RM: The importance of balanced pro-inflammatoty and anti-inflammatory mechanisms in diffuse lung disease. Respir Res 2002;3:5-11.
20. Moore KW, O'Garra A, De Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993;11:165-190.
21. Spiller F, Carlos D, Souto FO, De Freitas A, Soares FS, Vieira SM, Paula FJ, Alves-Filho JC, Cunha FQ: Alpha1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice. Diabetes 2012;61:1584-1591.
22. Feng YY, Xu XQ, Ji CB, Shi CM, Guo XR, Fu JF: Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease. Cell Physiol Biochem 2014;34:1983-97.
23. Baranowski M, Zabielski P, Bachnio-Zabielska AU, Harasim E, Chabowski A, Górski J: Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation. Cell Physiol Biochem 2014;33:1047-57.
24. Pang J, Xi C, Jin J, Han Y, Zhang TM: Relative quantitative comparison between lipotoxicity and glucotoxicity affecting the PARP-NAD-SIRT1 pathway in hepatocytes. Cell Physiol Biochem 2013;32:719-27.
25. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF: Neutrophils in development of multiple organ failure in sepsis. Lancet 2006;368:157-169.
26. Regnell SE, Lernmark A: Hepatic steatosis in type 1 diabetes. Rev Diabet Stud 2011;8:454-467.
27. Dandona P, Ghanim H, Green K, Sia CL, Abuaysheh S, Kuhadiya N, Batra M, Dhindsa S, Chaudhuri A: Insulin infusion suppresses while glucose infusion induces toll like receptors and high mobility group-B1 protein expression in mononuclear cells of type 1 diabetics. Am J Physiol Endocrinol Metab 2013;304:E810-8.
28. Giudici L, Velic A, Daryadel A, Bettoni C, Mohebbi N, Suply T, Seuwen K, Ludwig MG, Wagner CA: The proton-activated receptor GPR4 modulates glucose homeostasis by increasing insulin sensitivity. Cell Physiol Biochem 2013;32:1403-16.
29. Vonhorebeek I, Gunst J, Ellger B, Boussemaere M, Lerut E, Debaveye Y, Rabbani N, Thornalley PJ, Schetz M, Van Den Berghe G: Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney Int 2009;76:512-520.
30. Landgraf MA, Silva RC, Corrêa-Costa M, Hiyane MI, Carvalho MH, Landgraf RG, Câmara NO: Leptin downregulates LPS-induced lung injury: role of corticosterone and insulin. Cell Physiol Biochem 2014;33:835-46.